However, considerable inter-individual variabilities in both risk and severity of CIN, and in the beneficial effect of G-CSF prophylaxis were found among breast cancer patients (Agiro et al., 2016). This evidence concerns the gene CSF3 and cervical squamous intraepithelial neoplasia.